共 50 条
- [21] Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2019, 24
- [23] No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06): : 2243 - 2248
- [24] EFFECTIVE TREATMENT OF RECURRENT ACROMEGALY WITH A LONG-ACTIVE SOMATOSTATIN ANALOG (SANDOSTATIN) ARCHIVOS DE INVESTIGACION MEDICA, 1988, 19 (04): : 445 - 448
- [25] SUCCESSFUL TREATMENT OF OPHTHALMOPLEGIA IN ACROMEGALY WITH THE SOMATOSTATIN ANALOG SMS 201-995 NETHERLANDS JOURNAL OF MEDICINE, 1988, 32 (5-6): : 289 - 292
- [27] TREATMENT OF ACROMEGALY WITH A LONG-ACTING FORMULATION OF LANREOTIDE - A NEW SOMATOSTATIN ANALOG PRESSE MEDICALE, 1993, 22 (11): : 526 - 531
- [28] LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN BRITISH MEDICAL JOURNAL, 1985, 290 (6464): : 284 - 285
- [29] Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide Pituitary, 2012, 15 : 518 - 525
- [30] Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (08): : 2907 - 2914